HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) (BSE: 500124) (NSE: DRREDDY) today announced its consolidated financial results for the quarter ended June 30, 2015 under International Financial Reporting Standards (IFRS).
Q1 FY16: Key Highlights
* Consolidated revenues at Rs. 37.6 billion, year-on-year growth of 7%
* Gross Profit Margin at 61.1%, improved by 180 bps over last year
Help employers find you! Check out all the jobs and post your resume.
Q1 FY16: Key Highlights
* Consolidated revenues at Rs. 37.6 billion, year-on-year growth of 7%
* Gross Profit Margin at 61.1%, improved by 180 bps over last year
Help employers find you! Check out all the jobs and post your resume.
